BRMS1 expression in resected lung adenocarcinoma

The identification of prognostic markers for surgical resected cancers is a current issue for several malignancies (1,2). As regard lung adenocarcinoma (LUAD), despite curative-intent surgical resection, tumor recurrence and spread remain the primary causes of cancer-related death among patients with early stage.